Vaccination with autologous dendritic cells loaded with autologous tumor lysate or homogenate combined with immunomodulating radiotherapy and/or preleukapheresis IFN-α in patients with metastatic melanoma: a randomised „proof-of-principle“ phase II study

Long overall survival after dendritic cell vaccination in metastatic uveal melanoma patients

ISG12a mediates cell response to Newcastle disease viral infection

Melanoma cell lysate induces CCR7 expression and in vivo migration to draining lymph nodes of therapeutic human dendritic cells

Identification of pancreatic cancer-associated tumor antigen from HSP-enriched tumor lysate-pulsed human dendritic cells

Noninvasive radiofrequency treatment effect on mitochondria in pancreatic cancer cells

Therapeutic DC vaccination with IL-2 as a consolidation therapy for ovarian cancer patients: a phase I/II trial

Autologous tumor vaccine modified with recombinant new castle disease virus expressing IL-7 promotes antitumor immune response

Chemotherapy and Oncolytic Virotherapy: Advanced Tactics in the War against Cancer